AIA
GMAB icon

Arcadia Investment Advisors’s Genmab GMAB Stock Holding History

Arcadia Investment Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14
Closed -$572 – 159
2021
Q2 		$572 Buy
+14
New +$540 ﹤0.01% 213

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arcadia Investment Advisors's GMAB Position: Q3 2021 in Review

Arcadia Investment Advisors sold out of Genmab (GMAB) in Q3 2021, closing a stake of 14 shares — an estimated $572 sold.

Arcadia Investment Advisors first reported a position in GMAB in Q2 2021 and held it in 1 quarter. The position peaked at $572 in Q2 2021. 211 funds tracked by Wall St. Rank hold GMAB as of Q3 2021.

  • Arcadia Investment Advisors reported no remaining Genmab position as of Q3 2021 after selling out during the quarter.
  • Arcadia Investment Advisors sold 14 Genmab shares in Q3 2021, an estimated $572.
  • Arcadia Investment Advisors first reported a position in Genmab in Q2 2021 and held it in 1 quarter.
  • Arcadia Investment Advisors's Genmab position peaked at $572 in Q2 2021.
  • 211 funds tracked by Wall St. Rank held Genmab as of Q3 2021.

Based on Arcadia Investment Advisors's 13F filing for Q3 2021, filed 19 Dec 2024.